gemcitabine,paclitaxel
Not Tagged
['biomarker', 'neonax', 'ts,perio,i', 'norpact,1', 'norpact1', 'ts,perio,1']
 "pathway superiority depends on obtaining multimodal treatment in either pathway". #norpact1 not the first negative trial, #neonax. upfront surgery and adjuvant chemo remains standard of care for resectable pdac. #preopanc3 and other (biomarker driven) rcts might change this
HPB & GI Cancer Surgeon | Professor & Chair of Visceral Surgery | Director Department of Visceral, Vascular & Endocrine Surgery | @unimedhal | @surgery_science